Abstract:
The invention relates to a method for the preparation of amorphous silibinin (or its synonyms: silybin or silibin) derived from a milk thistle fruit extract having an increased release rate and improved absorbability or bioavailability, and to the use of amorphous silibinin for the treatment or prevention of liver diseases, preferably for the treatment of viral hepatitis, e.g. hepatitis B or C, in particular in a patient who will undergo or has undergone liver transplantation. Preferably, the amorphous silibinin is adapted for oral administration.
Abstract:
Aqueous polyurethane coating compositions are disclosed in this specification. The aqueous polyurethane coating compositions contain a polycarbonate-polyurethane resin component, an aminoplast resin component, and a polyester polyol component.
Abstract:
Aqueous polyurethane coating compositions are disclosed in this specification. The aqueous polyurethane coating compositions contain a polycarbonate-polyurethane resin component, an aminoplast resin component, and a polyacrylic polyol component.
Abstract:
The invention provides aqueous preparations having soft-feel properties, foams obtainable by mechanically foaming these preparations, and soft-feel coatings based on the foams. The preparations comprise aqueous polyurethane-polyurea dispersions, hydroxy-functional, aqueous or water-dilutable binders, polyisocyanates which may have been hydrophilically modified, and foam stabilizers.
Abstract:
The invention relates to water-dilutable, hydroxy-functional polyurethanes containing amide structural units, to a process for preparing them, to aqueous coating compositions prepared from them, and to their use for coating substrates.
Abstract:
The invention relates to water-dilutable, hydroxy-functional polyurethanes containing amide structural units, to a process for preparing them, to aqueous coating compositions prepared from them, and to their use for coating substrates.
Abstract:
The present invention relates to composite plastic moldings containing A) a thermoplastically formable, heat-resistant composite film having A1) a carrier film of a thermoplastic resin and A2) a layer of a heat-resistant soft touch coating on one side of the carrier film (A1) and B) a thermoplastic layer on the side of the carrier film (A1) facing away from the soft touch coating, wherein the soft touch coating (A2) is obtained from a composition containing i) polyurethanes and/or polyurethane-ureas which are free from hydroxyl and/or amine groups, ii) ionically modified polyurethanes and/or polyurethane-ureas which contain hydroxyl and/or amine groups, iii) at least one crosslinking agent, iv) optionally film-forming resins other than A1) or A2), and v) optionally additives. The present invention also relates to a process for the production of these composite moldings and their use in telecommunications equipment and in vehicle, ship and aircraft construction.
Abstract:
A process for preparing polyester-polyurethane resin dispersions that includes: A) reacting one or more polyol components i) having an average molecular weight of at least 300, at least one of the components being a polyester polyol and the fraction of polyester polyol based on aromatic polycarboxylic acids being more than 50% by weight with a polyisocyanate to form a prepolymer, B) dissolving the prepolymer in an organic solvent; C) reacting the prepolymer with aliphatic polyamines having a molecular weight of 60 to 300 or hydrazine and a hydrophilicized aliphatic diamine, D) precipitating the product from C) by adding water to form a dispersion, and E) removing the organic solvent. The resulting polyester-polyurethane resin dispersions can be used in coating compositions and in coating systems that include a substrate and one or more coating films, at least one of which includes the polyester-polyurethane resin dispersion.
Abstract:
The invention relates to solvent-borne polyurethane resins with a high carbonate group content which are dilutable in water, to aqueous coating compositions prepared thereof, to a process for preparing them and to their use.
Abstract:
The invention relates to a method for the preparation of amorphous silibinin (or its synonyms: silybin or silibin) derived from a milk thistle fruit extract having an increased release rate and improved absorbability or bioavailability, and to the use of amorphous silibinin for the treatment or prevention of liver diseases, preferably for the treatment of viral hepatitis, e.g. hepatitis B or C, in particular in a patient who will undergo or has undergone liver transplantation. Preferably, the amorphous silibinin is adapted for oral administration.